High-performance liquid chromatographic measurement of the novel anti-HIV agent 7,8-dihydrocostatolide (NSC 661123).
An HPLC assay was used to determine levels of a promising anti-HIV agent 7,8-dihydrocostatolide (DC; NSC 661123) in human and murine plasma. The structurally related compound costatolide (C) was found to be a suitable internal standard. Drug was extracted from human or murine plasma using a solid-phase C18 cartridge. The compound was eluted from an ODS analytical HPLC column using an acetonitrile-water mobile phase. Drug was quantified over the assay range of 19.5 to 625 ng/ml with excellent within- and between-day reproducibility. Data resulting from the use of the assay method for determination of dihydrocostatolide pharmacokinetics in mice are presented. This is the first report of a validated HPLC assay for determining DC levels in human and mouse plasma.